Insider Buy/Sell Ratio — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys142
Sells1527
Buy $$57.87M
Sell $$2.44B
Ratio1:42.20
% Change vs. Prior
Ratio -14.2%Value -66.2%
Technology
Buys132
Sells2883
Buy $$97.40M
Sell $$2.14B
Ratio1:22.00
% Change vs. Prior
Ratio -95.4%Value -84.5%
Consumer Cyclical
Buys39
Sells477
Buy $$3.09M
Sell $$1.03B
Ratio1:333.78
% Change vs. Prior
Ratio -90.2%Value -47.1%
Financial Services
Buys171
Sells568
Buy $$412.65M
Sell $$476.71M
Ratio1:1.16
% Change vs. Prior
Ratio +542.0%Value -30.7%
Industrials
Buys94
Sells382
Buy $$16.81M
Sell $$534.02M
Ratio1:31.78
% Change vs. Prior
Ratio -35.9%Value -68.2%
Energy
Buys36
Sells70
Buy $$2.38M
Sell $$218.07M
Ratio1:91.76
% Change vs. Prior
Ratio -12.0%Value -92.4%
Basic Materials
Buys44
Sells28
Buy $$8.65M
Sell $$206.71M
Ratio1:23.89
% Change vs. Prior
Ratio -85.1%Value +88.0%
Communication Services
Buys12
Sells259
Buy $$6.53M
Sell $$169.25M
Ratio1:25.90
% Change vs. Prior
Ratio -42.8%Value -70.5%
Consumer Defensive
Buys25
Sells173
Buy $$33.49M
Sell $$79.83M
Ratio1:2.38
% Change vs. Prior
Ratio +3102.2%Value -92.2%
Utilities
Buys20
Sells25
Buy $$8.23M
Sell $$41.59M
Ratio1:5.05
% Change vs. Prior
Ratio +12.7%Value -58.2%
Real Estate
Buys47
Sells42
Buy $$958.83K
Sell $$22.00M
Ratio1:22.95
% Change vs. Prior
Ratio -64.0%Value -76.5%
By Industry
Biotechnology
Buys117
Sells1089
Buy $$50.36M
Sell $$1.82B
Ratio1:36.18
% Change vs. Prior
Ratio -82.8%Value +44.5%
Software - Application
Buys54
Sells527
Buy $$66.56M
Sell $$491.31M
Ratio1:7.38
% Change vs. Prior
Ratio +377.8%Value -65.4%
Software - Infrastructure
Buys6
Sells983
Buy $$2.37M
Sell $$544.22M
Ratio1:230.10
% Change vs. Prior
Ratio -28.6%Value -50.7%
Computer Hardware
Buys0
Sells376
Buy $$0.00
Sell $$515.33M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value -65.9%
Furnishings, Fixtures & Appliances
Buys5
Sells9
Buy $$91.34K
Sell $$457.40M
Ratio1:5007.52
Financial - Capital Markets
Buys4
Sells122
Buy $$318.90M
Sell $$116.18M
Ratio2.74:1
Semiconductors
Buys46
Sells432
Buy $$942.92K
Sell $$420.21M
Ratio1:445.65
% Change vs. Prior
Ratio +411.3%Value -71.7%
Aerospace & Defense
Buys15
Sells145
Buy $$417.25K
Sell $$340.15M
Ratio1:815.21
% Change vs. Prior
Ratio +717.3%Value -39.9%
Specialty Retail
Buys9
Sells313
Buy $$2.12M
Sell $$311.32M
Ratio1:146.58
% Change vs. Prior
Ratio -62.7%Value -69.0%
Medical - Healthcare Information Services
Buys0
Sells152
Buy $$0.00
Sell $$238.67M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -87.0%
Chemicals - Specialty
Buys14
Sells10
Buy $$5.05M
Sell $$199.37M
Ratio1:39.51
Asset Management
Buys75
Sells44
Buy $$75.62M
Sell $$61.62M
Ratio1.23:1
Oil & Gas Refining & Marketing
Buys1
Sells21
Buy $$43.73K
Sell $$136.13M
Ratio1:3113.23
Travel Services
Buys0
Sells30
Buy $$0.00
Sell $$135.62M
RatioAll Sells
Financial - Credit Services
Buys0
Sells134
Buy $$0.00
Sell $$117.68M
RatioAll Sells
Transactions (6623)
BlackRock ESG Capital Allocation Term Trust (ECAT)
Saba Capital Management, L.P. — 10% Owner
Shares
111,432
Price
$15.40
Total Value
$1.72M
Shares Held After
17,930,744
% of Holdings
0.6%
AMPCO PITTSBURGH CORP (AP)
Lyon Samuel — President of Union Electric
Shares
9,500
Price
$9.82
Total Value
$93.27K
Shares Held After
181,233
% of Holdings
5.0%
GREENLIGHT CAPITAL RE, LTD. (GLRE)
Isaacs Ian — Director
Shares
4,000
Price
$16.06
Total Value
$64.25K
Shares Held After
51,191
% of Holdings
7.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,019
Price
$21.10
Total Value
$105.90K
Shares Held After
1,081,044
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,382
Price
$21.10
Total Value
$134.66K
Shares Held After
1,478,378
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
12,699
Price
$21.10
Total Value
$267.95K
Shares Held After
4,742,410
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,778
Price
$11.00
Total Value
$173.56K
Shares Held After
110,180
% of Holdings
12.5%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
4,222
Price
$11.00
Total Value
$46.44K
Shares Held After
125,958
% of Holdings
3.2%
ILLUMINA, INC. (ILMN)
Davies Scott M — Chief Legal Officer
Shares
615
Price
$180.00
Total Value
$110.70K
Shares Held After
20,953
% of Holdings
2.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,646
Price
$118.60
Total Value
$313.82K
Shares Held After
564,668
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,359
Price
$117.50
Total Value
$394.68K
Shares Held After
567,314
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,375
Price
$116.53
Total Value
$1.33M
Shares Held After
570,673
% of Holdings
2.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,389
Price
$115.57
Total Value
$969.52K
Shares Held After
582,048
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,289
Price
$114.65
Total Value
$147.78K
Shares Held After
590,437
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,437
Price
$113.70
Total Value
$163.39K
Shares Held After
591,726
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
100
Price
$111.89
Total Value
$11.19K
Shares Held After
593,163
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
86
Price
$110.79
Total Value
$9.53K
Shares Held After
593,263
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
265
Price
$110.30
Total Value
$29.23K
Shares Held After
593,349
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,011
Price
$108.83
Total Value
$218.86K
Shares Held After
593,614
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
46
Price
$129.61
Total Value
$5.96K
Shares Held After
529,718
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
23
Price
$108.02
Total Value
$2.48K
Shares Held After
595,625
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
305
Price
$128.69
Total Value
$39.25K
Shares Held After
529,764
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,399
Price
$107.30
Total Value
$150.11K
Shares Held After
595,648
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,507
Price
$127.37
Total Value
$446.69K
Shares Held After
530,069
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,089
Price
$118.60
Total Value
$2.26M
Shares Held After
3,113,085
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
223
Price
$126.71
Total Value
$28.26K
Shares Held After
533,576
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
24,268
Price
$117.50
Total Value
$2.85M
Shares Held After
3,132,174
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
522
Price
$125.82
Total Value
$65.68K
Shares Held After
533,799
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
81,500
Price
$116.53
Total Value
$9.50M
Shares Held After
3,156,442
% of Holdings
2.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,639
Price
$124.61
Total Value
$204.24K
Shares Held After
534,321
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
58,205
Price
$115.57
Total Value
$6.73M
Shares Held After
3,237,942
% of Holdings
1.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,517
Price
$123.62
Total Value
$187.53K
Shares Held After
535,960
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,229
Price
$114.65
Total Value
$1.06M
Shares Held After
3,296,147
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
698
Price
$122.67
Total Value
$85.62K
Shares Held After
537,477
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,215
Price
$113.70
Total Value
$1.16M
Shares Held After
3,305,376
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,689
Price
$121.38
Total Value
$690.53K
Shares Held After
538,175
% of Holdings
1.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
719
Price
$111.89
Total Value
$80.45K
Shares Held After
3,315,591
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
15,660
Price
$120.66
Total Value
$1.89M
Shares Held After
543,864
% of Holdings
2.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
614
Price
$110.79
Total Value
$68.03K
Shares Held After
3,316,310
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,144
Price
$119.71
Total Value
$615.79K
Shares Held After
559,524
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,915
Price
$110.30
Total Value
$211.22K
Shares Held After
3,316,924
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
337
Price
$129.61
Total Value
$43.68K
Shares Held After
2,862,351
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,351
Price
$108.83
Total Value
$1.56M
Shares Held After
3,318,839
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,197
Price
$128.69
Total Value
$282.73K
Shares Held After
2,862,688
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
159
Price
$108.02
Total Value
$17.18K
Shares Held After
3,333,190
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,075
Price
$127.37
Total Value
$3.19M
Shares Held After
2,864,885
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,994
Price
$107.30
Total Value
$1.07M
Shares Held After
3,333,349
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,609
Price
$126.71
Total Value
$203.88K
Shares Held After
2,889,960
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,716
Price
$125.82
Total Value
$467.55K
Shares Held After
2,891,569
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,711
Price
$124.61
Total Value
$1.46M
Shares Held After
2,895,285
% of Holdings
0.4%
Showing 3101–3150 of 6623 transactions (page 63 of 133)